Bo Liu

Dr. Bo Liu

Hubei University of Chinese Medicine
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2022 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
FWFei Wang
Fei Wang
CYChong Yuan
Chong Yuan
BLBo Liu
Bo Liu
YYYanfang Yang
Yanfang Yang
HWHezhen Wu
Hezhen Wu
Background: Breast cancer (BC) is one of the most common malignant tumors with the highest mortality in the world. Modern pharmacological studies have shown that Syringin has an inhibitory effect on many tumors, but its anti-BC efficacy and mechanism are still unclear. Methods: First, Syringin was isolated from Acanthopanax senticosus (Rupr. & Maxim.) Harms (ASH) by systematic solvent extraction and silica gel chromatography column. The plant name is composed of genus epithet, species additive words and the persons’ name who give its name. Then, the hub targets of Syringin against BC were revealed by bioinformatics. To provide a more experimental basis for later research, the hub genes which could be candidate biomarkers of BC and a ceRNA network related to them were obtained. And the potential mechanism of Syringin against BC was proved in vitro experiments. Results: Syringin was obtained by liquid chromatography-mass spectrometry (LC–MS), nuclear magnetic resonance (NMR), and high-performance liquid chromatography (HPLC). Bioinformatics results showed that MAP2K1, PIK3CA, HRAS, EGFR, Caspase3, and PTGS2 were the hub targets of Syringin against BC. And PIK3CA and HRAS were related to the survival and prognosis of BC patients, the PIK3CA-hsa-mir-139-5p-LINC01278 and PIK3CA-hsa-mir-375 pathways might be closely related to the mechanism of Syringin against BC. In vitro experiments confirmed that Syringin inhibited the proliferation and migration and promoted apoptosis of BC cells through the above hub targets. Conclusions: Syringin against BC via PI3K-AKT-PTGS2 and EGFR-RAS-RAF-MEK-ERK pathways, and PIK3CA and HRAS are hub genes for adjuvant treatment of BC. Graphical

26 May 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
FWFei Wang
Fei Wang
CYChong Yuan
Chong Yuan
HWHezhen Wu
Hezhen Wu
BLBo Liu
Bo Liu
YYYanfang Yang
Yanfang Yang
The increasing incidence and mortality rate of Breast cancer (BC) make it a major public health problem around the world. CXC chemokines can mediate the migration of immune cells and regulate apoptosis in tumor. However, the expression and prognostic value of them in BC and their targeted drugs have not been clarified. Therefore, in this study, ONCOMINE, GEPIA2.0, UALCAN, Venny2.1.0, cBioPortal, STRING, Gene MANIA, Pathway Commons, DAVID6.8, Omicshare, Cytoscape3.6.1, TIMER2.0, Drug Bank, TCMSP, RSCBPDB, PubChem, pkCSM, Chem Draw, AutoDockTools-1.5.6 and PyMOL were utilized for analysis. The expression of CXCL1-3, CXCL9-13 between BC and normal tissues was significantly different in all the three databases. And the expression of CXCL1-2, CXCL12-13 was correlated with the stages of BC. But only CXCL1-3 were prone to mutation, and negatively correlated with survival and prognosis of BC patients. Taken together, CXCL1-2 might be therapeutic targets and biomarkers for BC patients. In addition, both of them were associated with immune infiltration. The results of molecular docking showed that Quercetin was most likely to be developed as drugs that interacted directly with CXCL1-2. And GLU29 of CXCL1, ASP-1, PRO-96, TRP-47 and LEU-45 of CXCL2 were the most potential sites, which provided valuable reference for further study of pharmacodynamics and mechanism. In addition, the inhibitory effect of Quercetin on proliferation and promoting apoptosis of BC related cell lines were confirmed in vitro. Western blot and Real-Time PCR confirmed that it increased the expression of CXCL1-2 in MDA-MB-231 and MCF-7 cells.

25 August 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZHZongchao Hong
Zongchao Hong
TZTing Zhang
Ting Zhang
YZYing Zhang
Ying Zhang
ZXZhoutao Xie
Zhoutao Xie
YLYi Lu
Yi Lu
BLBo Liu
Bo Liu
Thrombotic diseases seriously threaten human life. Justicia, as a common Chinese medicine, is usually used for anti-inflammatory treatment, and further studies have found that it has an inhibitory effect on platelet aggregation. Therefore, it can be inferred that Justicia can be used as a therapeutic drug for thrombosis. This work aims to reveal the pharmacological mechanism of the anti-thrombotic effect of Justicia through network pharmacology combined with wet experimental verification. During the analysis, 461 compound targets were predicted from various databases and 881 thrombus-related targets were collected. Then, herb-compound-target network and protein–protein interaction network of disease and prediction targets were constructed and cluster analysis was applied to further explore the connection between the targets. In addition, Gene Ontology (GO) and pathway (KEGG) enrichment were used to further determine the association between target proteins and diseases. Finally, the expression of hub target proteins of the core component and the anti-thrombotic effect of Justicia’s core compounds were verified by experiments. In conclusion, the core bioactive components, especially justicidin D, can reduce thrombosis by regulating F2, MMP9, CXCL12, MET, RAC1, PDE5A, and ABCB1. The combination of network pharmacology and the experimental research strategies proposed in this paper provides a comprehensive method for systematically exploring the therapeutic mechanism of multi-component medicine.

25 January 2018 in BMC Chemistry
Verified
Journal Article
Open access
PDF file
BLBo Liu
Bo Liu
YYYanfang Yang
Yanfang Yang
HLHongbin Liu
Hongbin Liu
ZXZhoutao Xie
Zhoutao Xie
QLQun Li
Qun Li
HWHezhen Wu
Hezhen Wu
The Acanthaceae family is an important source of therapeutic drugs and ethno medicines. There are many famous medicinal plants from this family, such as Andrographis paniculata, Baphicacanthus cusia, and Dicliptera chinensis. Justicia procumbens (J. procumbens) is widely distributed in tropical and sub-tropical of the world. It has long been used in traditional Chinese medicine for cancer. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed the ethyl acetate extract of J. procumbens had a cytotoxic activity. Therefore, qualitative and quantitative analysis of the chemical constituents in the ethyl acetate extract was important for understanding its pharmacological mechanism. A high-performance liquid chromatography with diode array detection coupled to electrospray ionisation quadrupole time-of-flight tandem mass spectrometry procedure was established. Eleven dibenzylbutanes and four arylnaphthalenes were confirmed by HPLC–DAD–ESI–QTOF–MS analysis. A novel dibenzylbutane (5-methoxy-4,4′-di-O-methylsecolariciresinol-9′-monoacetate) and seven isomers of arylnaphthalene were isolated and characterized by NMR and QTOF–MS. Compounds 1, 2, and 13 were detected for the first time. The content of six lignans were determinated in the ethyl acetate extract. This study showed that the cytotoxic activity assay of J. procumbens could be mainly attributed to the constituents of lignans. The bioactivity of the ethyl acetate extract and determined compounds support the traditional use of this plant in cancer. These chemical constituents may be developed as novel therapeutics.

16 May 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
BLBo Liu
Bo Liu
TZTing Zhang
Ting Zhang
ZXZhou-Tao Xie
Zhou-Tao Xie
ZHZong-Chao Hong
Zong-Chao Hong
YLYi Lu
Yi Lu
HWHezhen Wu
Hezhen Wu

1 January 2025 in Italian Journal of Food Science
Verified
Journal Article
Open access
PDF file
ZWZhan Wang
Zhan Wang
DTDong Tan
Dong Tan
KZKemeng Zhao
Kemeng Zhao
WSWangyang Shen
Wangyang Shen
JXJia Xiwu
Jia Xiwu
BLBo Liu
Bo Liu
This study investigated wheat bran dietary fiber (WBDF) using the twin-screw extrusion method, with wheat bran as the primary raw material. The research examined the physicochemical properties, cholesterol and sodium cholate adsorption capacity, thermogravimetric analysis, X-ray diffraction, and functional characteristics. Animal experiments were conducted to assess its impact on improving constipation. Results indicated that extru-sion-modified WBDF (E-WBDF) exhibited higher water-holding capacity (WHC), oil-holding capacity (OHC), water swelling capacity (WSC), and stronger cholesterol and sodium cholate adsorption capacities (CAC and SCAC). Additionally, E-WBDF showed greater DPPH and ABTS scavenging activities compared to WBDF. In mouse models of slow transit constipation, both WBDF and E-WBDF significantly alleviated constipation, with E-WBDF demonstrating superior efficacy. These findings highlight that E-WBDF could serve as a promising functional food additive to enhance intestinal function.